DHCNL logo

Diversified Healthcare Trust 6.25% Senior Notes Due 2046

DHCNLβ€”
Earnings Nov 2 Β· PostUS Equity
$20.30β–² $0.93 (+4.80%)
Pre-market Β· at close
πŸ””
Track DHCNL
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 4.8%
7dβ–² 10.9%
14dβ–² 11.5%
30dβ–² 8.4%
ytdβ–² 15.8%
1yβ–² 14.5%
🏦Market Cap
β€”
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$19.68 – $20.60
52-Week Range
β€”
Volume (shares)
400
Avg Volume (shares)
β€”
Shares Outstanding
β€”
Next Earnings
2026-11-02

Fundamentals Snapshot

Annual Revenue
$1.54B
Last Q Revenue
$365M
P/E Ratio
β€”
P/S Ratio
β€”
EPS (TTM)
β€”
Dividend Yield
β€”
Dilution (1yr)
+0.1%
DHCNL logo

Diversified Healthcare Trust 6.25% Senior Notes Due 2046

DHCNL
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.5Bβ–² +2.8% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-16.0%β–Ό βˆ’193.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$39Mβ–Ό βˆ’117.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$20Mβ–Ό βˆ’117.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
240.3Mβ–² +0.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$2.3Bβ–² +$470M YoY
StockOtter Β· stockotter.space

About Diversified Healthcare Trust 6.25% Senior Notes Due 2046

A company profile for Diversified Healthcare Trust 6.25% Senior Notes Due 2046 isn’t available yet β€” check back soon.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Buy
9 analysts
Strong Buy1
Buy5
Hold3
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.